Panel participants share an optimistic outlook for integrating new innovations, tacking community-level challenges, and more.
Miranda Schmalfuhs
Advertisement
Miranda Schmalfuhs is the associate group social media editor of Pharmaceutical Executive, Pharmaceutical Commerce, and Applied Clinical Trials and can be reached at mschmalfuhs@mjhlifesciences.com.
Articles by Miranda Schmalfuhs
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
A new offering in collaboration with Progyny, Inc makes fertility/family-building services more accessible and equitable.
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
The new digital ecosystem offers scalable and flexible environment for clinical development.
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
This acquisition will help generate data from over four million members of MyHealthTeams’ opted-in patient universe.
The latest news for pharma industry insiders.
The addition of Peregrine builds on Klick’s market access execution capabilities.
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
The latest news for pharma industry insiders.
In this Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses making advanced fertility treatments more accessible and affordable for a wider range of patients.
In this Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), speaks about exciting developments in fertility treatment that he anticipates in the next few years.
In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), talks about advancements in technology and data analysis that could lead to more personalized fertility treatments.
Check out our top five most engaged social media posts from the year 2024.
In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), how new radiological techniques are revolutionizing the diagnosis of conditions like endometriosis and the impact it will have on patients.
In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), explains the ethical considerations of using social media to share personal and professional experiences, especially in a field as sensitive as fertility.
In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses the biggest misconceptions about fertility that he sees circulating on social media and work he does to correct and prevent them.
The top five episodes of our podcast in the year 2024, highlighted.
In this part of his Pharmaceutical Executive video interview, Peter Ax, CEO of UpScriptHealth, discusses regulatory challenges and opportunities that telehealth companies face in 2025.
The latest news for pharma industry insiders.
In this part of his Pharmaceutical Executive video interview, Peter Ax, CEO of UpScriptHealth, shares some specific examples of how AI is being used to personalize treatment plans, monitor patient progress, and identify potential issues.
The latest news for pharma industry insiders.
In this part of his Pharmaceutical Executive video interview, Peter Ax, CEO of UpScriptHealth, explores the key factors driving the increasing number of partnerships between telehealth and pharmaceutical/medical device companies.
The latest news for pharma industry insiders.
Advertisement
